StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.99−0.25 (-4.77%)

Close on Nov 17, 2026Market cap $489.46MP/E –Yield –

aTYR PHARMA total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

aTYR PHARMA's total debt was $3.06M at Sep 30, 2020. For fiscal 2019 it was $8.74M, down 45.5% from the year before. The highest annual figure on record is $19.73M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$8.74M-45.5%
FY2018Dec 31, 2018$16.03M-18.8%
FY2017Dec 31, 2017$19.73M+106.9%
FY2016Dec 31, 2016$9.54M+85.5%
FY2015Dec 31, 2015$5.14M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$3.06M-71.1%
Q2 FY2020Jun 30, 2020$4.98M-59.9%
Q1 FY2020Mar 31, 2020$6.87M-51.8%
Q4 FY2019Dec 31, 2019$8.74M-45.5%
Q3 FY2019Sep 30, 2019$10.59M-40.6%
Q2 FY2019Jun 30, 2019$12.42M-36.5%
Q1 FY2019Mar 31, 2019$14.23M-28.8%
Q4 FY2018Dec 31, 2018$16.03M-18.8%
Q3 FY2018Sep 30, 2018$17.81M+20.8%
Q2 FY2018Jun 30, 2018$19.57M+34.2%
Q1 FY2018Mar 31, 2018$19.98M+108.7%
Q4 FY2017Dec 31, 2017$19.73M+106.9%
Q3 FY2017Sep 30, 2017$14.75M–
Q2 FY2017Jun 30, 2017$14.58M–
Q1 FY2017Mar 31, 2017$9.57M–
Q4 FY2016Dec 31, 2016$9.54M–

More aTYR PHARMA figures

See a number that looks wrong?